We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 11-20 of 1,566

Cialis Canadian Patent Knocks Out Double Patenting Challenge
  • Bereskin & Parr LLP
  • Canada
  • January 20 2017

Eli Lilly's Canadian patent on treatment of erectile dysfunction with Cialis continues to defy all challengers. A recent appeal case originated from

Bill C-30 passes Senate today to usher in changes to Canadian pharma patent regulations
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • May 11 2017

Bill C-30 was passed by the Senate today, May 11, 2017 without amendment. Bill C-30 is the bill that will implement the Canada-European Union

Competitionantitrust law
  • Dentons
  • USA, Canada, China, European Union, Germany, OECD, United Kingdom, Australia
  • February 9 2017

In the wake of the 2016 elections, we now await the decision as to who will be the "antitrust guard" at the top of the US Department

What the Supreme Court of Canada was not told about patent utility
  • Gowling WLG
  • Canada
  • May 11 2017

On November 8, 2016 the Supreme Court of Canada (“SCC”) heard an appeal by Astrazeneca regarding the validity of a patent covering its NEXIUM product

Update on implementing CETA in Canada - What pharmaceutical companies need to know
  • Marks & Clerk
  • Canada, European Union
  • May 10 2017

The Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union was approved by all 28 EU member states in October 2016

April 2017 International Trade Compliance Update
  • Baker McKenzie
  • USA, Canada, European Union, United Kingdom
  • April 12 2017

The WTO announced that WTO members discussed five new or enhanced proposals to advance services negotiations at meetings of the Working Party on

Just How Predictable Must the Invention Be to Lose Patent Protection? Depends on the Inventive Concept
  • Bennett Jones LLP
  • Canada
  • April 21 2017

Only a true invention can be patented; a patent claim to an invention is not valid if the invention was obvious. Assessing obviousness can be thought

Prohibition order denied against Apotex for generic tenofovir disoproxilemtricitabine
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • October 31 2016

The Federal Court dismissed Gilead's prohibition application against Apotex for its tenofovir disoproxil fumarate (TDF) and emtricitabine fixed dose

Appeal of a finding of non-infringement of a U.S. Patent dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • May 31 2017

The Ontario Court of Appeal dismissed an appeal of the Trial Judge's decision finding that the Respondent had not infringed the Appellant's patent in

Bayer Inc. v. Cobalt Pharmaceuticals Company, 2013 FC 1061 : methods of medical treatment held unpatentable, promise of a patent must be explicit
  • Heenan Blaikie LLP
  • Canada
  • November 11 2013

On October 22, 2013, the Federal Court released its decision regarding Bayer's application to prohibit the Minister of Health from issuing Cobalt a